Outcome Comparison of High-Risk Native American Patients Who Did or Did Not Receive Monoclonal Antibody Treatment for COVID-19.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 34546375.
- Also identified by DOI 10.1001/jamanetworkopen.2021.25866 and PMC identifier 8456379.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This quality improvement study compares outcomes among high-risk Native American patients who did or did not receive monoclonal antibody treatment for COVID-19.
Medical subject headings
- Antibodies, Monoclonal, Humanized
- Hospital Mortality
- Hospitalization
- COVID-19 Drug Treatment
- American Indian or Alaska Native